Elevated thymosin β15 expression is associated with progression and metastasis of non-small cell lung cancer

APMIS

Volumn 116, Issue 6, 2008, Pages 484-490

  Gu, Yu Mei ^b   Li, Shu Yu ^b   Qiu, Xue Shan ^a   Wang, En Hua ^b  

^a CHINA MEDICAL UNIVERSITY   (China)

^b NONE

Author keywords

Metastasis; Non small cell lung cancer; Progression; Thymosin 15

Indexed keywords

MESSENGER RNA; PROTEIN THYMOSIN BETA 15; THYMOSIN;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER STAGING; CELL MIGRATION; CONTROLLED STUDY; CYTOPLASM; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; CELL MOTION; DISEASE COURSE; GENETIC TRANSFECTION; LUNG TUMOR; METABOLISM; METASTASIS; MIDDLE AGED; PATHOLOGY; TUMOR CELL LINE; UPREGULATION;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL MOVEMENT; DISEASE PROGRESSION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; RNA, MESSENGER; THYMOSIN; TRANSFECTION; UP-REGULATION;

EID: 49649119008     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2008.00918.x     Document Type: Article

References (26)

1. Low TL, Thurman GB, McAdoo M, McClure J, Rossio JL, Naylor PH, et al. The chemistry and biology of thymosin. I. Isolation, characterization, and biological activities of thymosin alpha1 and polypeptide beta1 from calf thymus. J Biol Chem 1979 254 : 981 6.
2. Choe J, Sun W, Yoon SY, Rhyu IJ, Kim EH, Kim H. Effect of thymosin beta15 on the branching of developing neurons. Biochem Biophys Res Commun 2005 331 : 43 9.
3. Koutrafouri V, Leondiadis L, Ferderigos N, Avgoustakis K, Livaniou E, Evangelatos GP, et al. Synthesis and angiogenetic activity in the chick chorioallantoic membrane model of thymosin beta-15. Peptides 2003 24 : 107 15.
4. Huff T, Müller CS, Otto AM, Netzker R, Hannappel E. beta-Thymosins, small acidic peptides with multiple functions. Int J Biochem Cell Biol 2001 33 : 205 20.
5. Eadie JS, Kim SW, Allen PG, Hutchinson LM, Kantor JD, Zetter BR, et al. C-terminal variations in beta-thymosin family members specify functional differences in actin-binding properties. J Cell Biochem 2000 77 : 277 87.
6. Bao L, Zetter BR. Molecular cloning and structural characterization of the rat thymosin beta15 gene. Gene 2000 260 : 37 44.
7. Bao L, Loda M, Janmey PA, Stewart R, Anand-Apte B, Zetter BR. Thymosin beta 15: a novel regulator of tumor cell motility upregulated in metastatic prostate cancer. Nat Med 1996 2 : 1322 8.
8. Bao L, Loda M, Zetter BR. Thymosin beta15 expression in tumor cell lines with varying metastatic potential. Clin Exp Metastasis 1998 16 : 227 33.
9. Gold JS, Bao L, Ghoussoub RA, Zetter BR, Rimm DL. Localization and quantitation of expression of the cell motility-related protein thymosin beta15 in human breast tissue. Mod Pathol 1997 10 : 1106 12.
10. Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC. Pathology and Genetics of Tumors of the Lung, Pleura, Thymus and Heart. World Health Organization Classification of tumors. Lyon : IARC Press, 2004.
11. Watanabe Y. TNM classification for lung cancer. Ann Thorac Cardiovasc Surg 2003 9 : 343 50.
12. Zhu W, Zheng J, Fang W. Isolation and characterization of human lung cancer cell subline with different metastatic potential. Zhonghua Bing Li Xue Za Zhi 1995 24 : 136 8.
13. Liu CR, Ma CS, Ning JY, You JF, Liao SL, Zheng J. Differential thymosin beta 10 expression levels and actin filament organization in tumor cell lines with different metastatic potential. Chin Med J (Engl) 2004 117 : 213 8.
14. Holzbeierlein J, Lal P, LaTulippe E, Smith A, Satagopan J, Zhang L, et al. Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance. Am J Pathol 2004 164 : 217 27.
15. Varambally S, Yu J, Laxman B, Rhodes DR, Mehra R, Tomlins SA, et al. Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression. Cancer Cell 2005 8 : 393 406.
16. Yu YP, Landsittel D, Jing L, Nelson J, Ren B, Liu L, et al. Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy. J Clin Oncol 2004 22 : 2790 9.
17. Sotiriou C, Wirapati P, Loi S, Harris A, Fox S, Smeds J, et al. Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. J Natl Cancer Inst 2006 98 : 262 72.
18. Weigelt B, Hu Z, He X, Livasy C, Carey LA, Ewend MG, et al. Molecular portraits and 70-gene prognosis signature are preserved throughout the metastatic process of breast cancer. Cancer Res 2005 65 : 9155 8.
19. van 't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002 415 : 530 6.
20. Wang Y, Klijn JG, Zhang Y, Sieuwerts AM, Look MP, Yang F, et al. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 2005 365 : 671 9.
21. Shai R, Shi T, Kremen TJ, Horvath S, Liau LM, Cloughesy TF, et al. Gene expression profiling identifies molecular subtypes of gliomas. Oncogene 2003 22 : 4918 23.
22. Bhattacharjee A, Richards WG, Staunton J, Li C, Monti S, Vasa P, et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci U S A 2001 98 : 13790 5.
23. Ginos MA, Page GP, Michalowicz BS, Patel KJ, Volker SE, Pambuccian SE, et al. Identification of a gene expression signature associated with recurrent disease in squamous cell carcinoma of the head and neck. Cancer Res 2004 64 : 55 63.
24. Hutchinson LM, Chang EL, Becker CM, Shih MC, Brice M, DeWolf WC, et al. Use of thymosin beta15 as a urinary biomarker in human prostate cancer. Prostate 2005 64 : 116 27.
25. Hutchinson LM, Chang EL, Becker CM, Ushiyama N, Behonick D, Shih MC, et al. Development of a sensitive and specific enzyme-linked immunosorbent assay for thymosin beta15, a urinary biomarker of human prostate cancer. Clin Biochem 2005 38 : 558 71.
26. Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics. CA Cancer J Clin 2001 51 : 15 36.